Akeso (HKSE:09926) Price-to-Tangible-Book : 8.66 (As of May. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Akeso Price-to-Tangible-Book?

As of today (2024-05-15), Akeso's share price is HK$49.20. Akeso's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$5.68. Hence, Akeso's Price to Tangible Book Ratio of today is 8.66.

The historical rank and industry rank for Akeso's Price-to-Tangible-Book or its related term are showing as below:

HKSE:09926' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.52 Med: 8.24 Max: 13.09
Current: 8.66

During the past 6 years, Akeso's highest Price to Tangible Book Ratio was 13.09. The lowest was 7.52. And the median was 8.24.

HKSE:09926's Price-to-Tangible-Book is ranked worse than
84.47% of 1230 companies
in the Biotechnology industry
Industry Median: 2.8 vs HKSE:09926: 8.66

A closely related ratio is called PB Ratio. As of today, Akeso's share price is HK$49.20. Akeso's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$6.10. Hence, Akeso's P/B Ratio of today is 8.06.

Akeso Price-to-Tangible-Book Historical Data

The historical data trend for Akeso's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Price-to-Tangible-Book Chart

Akeso Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.32

7.52

13.09

8.16

Akeso Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						7.52	6.53	13.09	5.46	8.16

Competitive Comparison of Akeso's Price-to-Tangible-Book

For the Biotechnology subindustry, Akeso's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akeso's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akeso's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Akeso's Price-to-Tangible-Book falls into.

Akeso Price-to-Tangible-Book Calculation

Akeso's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	49.20	/	5.684
	=	8.66

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Akeso Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Akeso's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso (HKSE:09926) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (HKSE:09926) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

AKESF:USA 4RY:Germany

Address

6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437

Website

https://www.akesobio.com

Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.

Akeso (HKSE:09926) Headlines

No Headlines